Shi Min, Li Honyu, Liang Runyu, Lin Haiyan, Tang Qiang
Heilongjiang University of Chinese Medicine, Harbin, 150040, Heilongjiang, China.
Biogerontology. 2025 Feb 7;26(2):55. doi: 10.1007/s10522-025-10193-3.
Aging is a physiological/pathological process accompanied by progressive impairment of cellular function, leading to a variety of aging-related diseases. STAT3 is one of the core regulatory factors of aging. It is involved in body metabolism, development and senescence, cell apoptosis and so on. During the aging process, the changes of growth factors and cytokines will cause the activation of STAT3 to varying degrees, regulate the inflammatory pathways related to aging, regulate body inflammation, mitochondrial function, cell aging and autophagy to regulate and influence the aging process. Drugs targeting STAT3 can treat senescence related diseases. This review summarizes the role of STAT3 signaling factors in the pathogenesis of aging, including mitochondrial function, cellular senescence, autophagy, and chronic inflammation mediated by inflammatory pathways. Finally, the key regulatory role of STAT3 in senescence related diseases is emphasized. In summary, we reveal that drug development and clinical application targeting STAT3 is one of the key points in delaying aging and treating aging-related diseases in the future.
衰老是一个生理/病理过程,伴随着细胞功能的进行性损害,导致各种与衰老相关的疾病。信号转导子和转录激活子3(STAT3)是衰老的核心调控因子之一。它参与身体代谢、发育与衰老、细胞凋亡等过程。在衰老过程中,生长因子和细胞因子的变化会不同程度地导致STAT3激活,调节与衰老相关的炎症途径,调控身体炎症、线粒体功能、细胞衰老和自噬,从而调节和影响衰老进程。靶向STAT3的药物可治疗衰老相关疾病。本综述总结了STAT3信号因子在衰老发病机制中的作用,包括线粒体功能、细胞衰老、自噬以及炎症途径介导的慢性炎症。最后,强调了STAT3在衰老相关疾病中的关键调控作用。总之,我们揭示了靶向STAT3的药物研发和临床应用是未来延缓衰老及治疗衰老相关疾病的关键点之一。